EU’s Joint Regulatory/HTA System Praised, But Improvements Needed
Access To New Drugs Is Still Problematic In Some Countries
Panelists at the virtual DIA Europe 2020 conference heard some good news about progress with the EU’s parallel consultation system for scientific advice, and some not so good news about continuing differences in health technology assessments at national level across Europe.
